16S核糖体RNA基因测序评估高原红细胞增多症患者血液菌群特征

黄沛; 黄河; 谢慎威; 吴玉; 钟志凤; 董华平; 周思敏; 李鹏; 谢佳新

doi:10.16016/j.2097-0927.202309007

您当前的位置：

首页 >

文章列表页 >

16S核糖体RNA基因测序评估高原红细胞增多症患者血液菌群特征

军事医学 | 更新时间：2026-01-09

- 16S核糖体RNA基因测序评估高原红细胞增多症患者血液菌群特征
- Characteristics of blood microbiota in high altitude polycythemia patients by 16S rRNA gene sequencing
- 陆军军医大学学报 2024年46卷第10期页码：1075-1082
- 作者机构：
  
  1.400038 重庆，陆军军医大学(第三军医大学)高原军事医学系高原作业医学教研室
  2.730000 兰州，联勤保障部队第九四〇医院神经内科
  3.857000 西藏日喀则，陆军第九五三医院健康管理科
- 作者简介：
  
  [李鹏，E-mail：lipengtmmu@163.com LI Peng, E-mail: lipengtmmu@163.com
  [谢佳新，E-mail：xiejiaxin1006@163.com XIE Jiaxin, E-mail: xiejiaxin1006@163.com
- 基金信息：
  
  甘肃省自然科学基金(22JR11RA008);第九四〇医院院内课题(2022yxky005);甘肃省卫生健康行业科研项目(GSWSKY2022-47)
- DOI：10.16016/j.2097-0927.202309007
  中图分类号： R195.4;R446.119;R555.1
- 收稿：2023-09-01，
  
  修回：2023-12-28，
  
  纸质出版：2024-05-30
- 稿件说明：
移动端阅览
黄沛, 黄河, 谢慎威, 等. 16S核糖体RNA基因测序评估高原红细胞增多症患者血液菌群特征[J]. 陆军军医大学学报, 2024,46(10):1075-1082.

Pei HUANG, He HUANG, Shenwei XIE, et al. Characteristics of blood microbiota in high altitude polycythemia patients by 16S rRNA gene sequencing[J]. Journal of Army Medical University, 2024, 46(10): 1075-1082.
黄沛, 黄河, 谢慎威, 等. 16S核糖体RNA基因测序评估高原红细胞增多症患者血液菌群特征[J]. 陆军军医大学学报, 2024,46(10):1075-1082. DOI： 10.16016/j.2097-0927.202309007.

Pei HUANG, He HUANG, Shenwei XIE, et al. Characteristics of blood microbiota in high altitude polycythemia patients by 16S rRNA gene sequencing[J]. Journal of Army Medical University, 2024, 46(10): 1075-1082. DOI： 10.16016/j.2097-0927.202309007.

摘要

目的

探讨高原红细胞增多症(high altitude polycythemia，HAPC)患者血液菌群变化特征及其与HAPC发病风险的相关性。

方法

采用横断面研究设计方案，以2021年在西藏日喀则陆军第九五三医院健康管理科参加体检的41名HAPC患者(HAPC组)和41名高原健康人员(对照组)为研究对象。通过高通量测序技术对血液细菌16 S核糖体RNA(16S rRNA)基因的V3-V4可变区进行检测，比较分析HAPC组和对照组血液菌群组成情况和差异。

结果

2组人员均为汉族男性，年龄、体质量指数及高原移居时间等基线数据比较差异无统计学意义(

＞0.05)。菌群多样性分析显示，HAPC组中反映血液菌群α-多样性的Simpson指数[(0.931±0.005)

(0.907±0.008)，

＜0.05

]

、Goods Coverage指数[(0.998±0.001)

(0.997±0.001)，

＜0.001)

]

和Pielou指数[(

0.597±0.011)

(0.567±0.009)，

＜0.05)

]

显著高于对照组。2组间β多样性差异有统计学意义(

0.01)。菌群相对丰度分析显示，HAPC组血液嗜糖假单胞菌属(

Pelomonas

)[(0.046±0.004)

(0.033±0.003)，

＜0.05)

]

、固氮螺菌属(

Azospirillum

)[(0.046±0.006)

(0.021±0.003)，

＜0.01)

]

、食酸菌属(

Acidovorax

)[(0.032±0.003)

(0.019±0.002)，

＜0.05)

]

的相对丰度均显著高于对照组。特征性细菌LEfSe分析显示，HAPC组标志菌群是α-变形菌纲，对照组标志菌群是毛螺菌科。

结论

HAPC患者较高原健康人群的血液菌群在多样性、相对丰度及特征性菌类方面发生显著变化，这类变化可能与HAPC的发生发展密切关联。

Abstract

Objective

To investigate the changes in blood microbiota in patients with high altitude polycythemia (HAPC) and the correlation with the risk of HAPC.

Methods

A cross-sectional trial was carried out among 41 HAPC patients (HAPC group) and 41 healthy plateau individuals (control group) who took physical examination in the Health Management Department of No. 953 Hospital of PLA Army in 2021. High-throughput sequencing technology was used to detect the V3-V4 variable region of the 16S ribosomal RNA (16S rRNA) gene in the blood smaples

and the composition and difference of the blood microbiota were compared and analyzed between the 2 groups.

Results

All the participants were male and Han people

and there were no significant differences in baseline data such as age

body mass index and plateau migration time between the 2 groups (

0.05). The α-diversity of blood microbiota in the HAPC group

including the Simpson index (0.931±0.005

0.907±0.008

0.05)

Goods Coverage index (0.998±0.001

0.997±0.001

0.001) and Pielou index (0.597±0.011

0.567±0.009

0.05) were significantly higher than th

ose in the control group. Meanwhile

obvious difference was observed in the β diversity between the 2 groups (

0.01). The relative abundance analysis of bacteria showed that

Pelomonas

(0.046±0.004

0.033±0.003

0.05)

Azospirillum

(0.046±0.006

0.021±0.003

0.01)

Acidovorax

(0.032±0.003

0.019±0.002

Azospirillum

(0.046±0.006

0.021±0.003

0.01) and

Acidovorax

(0.032±0.003

0.019±0.002

0.05) were statistically higher in the HAPC group than the control group. LEfSe analysis showed that the characteristic blood microbiota of the HAPC group were α-

Proteobacteria

and those of control group were

Trichospiridae

Conclusion

Significant changes are found in diversity

relative abundance and characteristic bacteria of the blood microbiota between the HAPC patients and healthy people at the high altitude

which might be closely associated with the occurrence and development of HAPC.

关键词

Keywords

references

LEÓN-VELARDE F, MAGGIORINI M, REEVES J T, et al . Consensus statement on chronic and subacute high altitude diseases[J ] . High Alt Med Biol, 2005, 6(2): 147-157. DOI: 10.1089/ham.2005.6.147.

SONG Z, ZHANG A X, LUO J, et al . Prevalence of high-altitude polycythemia and hyperuricemia and risk factors for hyperuricemia in high-altitude immigrants[J ] . High Alt Med Biol, 2023, 24(2): 132-138. DOI: 10.1089/ham.2022.0133.

SU J, LI Z Q, CUI S, et al . The local HIF-2α/EPO pathway in the bone marrow is associated with excessive erythrocytosis and the increase in bone marrow microvessel density in chronic mountain sickness[J ] . High Alt Med Biol, 2015, 16(4): 318-330. DOI: 10.1089/ham.2015.0015.

MA J, JI L H, LI Z Q, et al . Downregulation of intrinsic apoptosis pathway in erythroblasts contributes to excessive erythrocytosis of chronic mountain sickness[J ] . Blood Cells Mol Dis, 2019, 76: 25-31. DOI: 10.1016/j.bcmd.2019.01.002.

CHEN K, LI N, FAN F F, et al . Tibetan medicine Duoxuekang capsule ameliorates high-altitude polycythemia accompanied by brain injury[J ] . Front Pharmacol, 2021, 12: 680636. DOI: 10.3389/fphar.2021.680636.

POTGIETER M, BESTER J, KELL D B, et al . The dormant blood microbiome in chronic, inflammatory diseases[J ] . FEMS Microbiol Rev, 2015, 39(4): 567-591. DOI: 10.1093/fe msre/fuv013.

SHREINER A B, KAO J Y, YOUNG V B. The gut microbiome in health and in disease[J]. Curr Opin Gastroenterol, 2015, 31(1): 69-75. DOI: 10.1097/MOG.0000000000000139.

PRAL L P, FACHI J L, CORRÊA R O, et al . Hypoxia and HIF-1 as key regulators of gut microbiota and host interactions[J ] . Trends Immunol, 2021, 42(7): 604-621. DOI: 10.1016/j.it.2021.05.004.

HAN N, PAN Z Y, LIU G W, et al . Hypoxia: the "invisible pusher" of gut microbiota[J ] . Front Microbiol, 2021, 12: 690600. DOI: 10.3389/fmicb.2021.690600.

MCKENNA Z J, GORINI PEREIRA F, GILLUM T L, et al . High-altitude exposures and intestinal barrier dysfunction[J ] . Am J Physiol Regul Integr Comp Physiol, 2022, 322(3): R192-R203. DOI: 10.1152/ajpregu.00270.2021.

HAKANSSON A, MOLIN G. Gut microbiota and inflammation[J]. Nutrients, 2011, 3(6): 637-682. DOI: 10.3390/nu3060637.

LIU Y S, HUANG H, ZHOU S M, et al . Excessive iron availability caused by disorders of interleukin-10 and interleukin-22 contributes to high altitude polycythemia[J ] . Front Physiol, 2018, 9: 548. DOI: 10.3389/fphys.2018.00548.

YANG W J, YU T M, HUANG X S, et al . Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity[J ] . Nat Commun, 2020, 11(1): 4457. DOI: 10.1038/s41467-020-18262-6.

SUN M M, WU W, CHEN L, et al . Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis[J ] . Nat Commun, 2018, 9(1): 3555. DOI: 10.1038/s41467-018-05901-2.

SMITH P M, HOWITT M R, PANIKOV N, et al . The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis[J ] . Science, 2013, 341(6145): 569-573. DOI: 10.1126/science.1241165.

KIM C H, PARK J, KIM M. Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation[J]. Immune Netw, 2014, 14(6): 277-288. DOI: 10.4110/in.2014.14.6.277.

GRIMES D A, SCHULZ K F. An overview of clinical research: the lay of the land[J]. Lancet, 2002, 359 (9300): 57-61. DOI: 10.1016/S0140-6736(02)07283-5.

祁生贵, 吴天一. 慢性高原病诊断标准及相关研究[J]. 高原医学杂志, 2015, 25 (4): 1-11. DOI: CNKI:SUN:GYYZ.0.2015-04-001.

QI S G, WU T Y. Diagnostic criteria and related studies on chronic high-altitude disease[J]. J High Altitude Med, 2015, 25(4): 1-11. DOI: CNKI:SUN:GYYZ.0.2015-04-001.

CASTILLO D J, RIFKIN R F, COWAN D A, et al . The healthy human blood microbiome: fact or fiction?[J ] . Front Cell Infect Microbiol, 2019, 9: 148. DOI: 10.3389/fcimb.2019.00148.

BHATTACHARYYA M, GHOSH T, SHANKAR S, et al . The conserved phylogeny of blood microbiome[J ] . Mol Phylogenet Evol, 2017, 109: 404-408. DOI: 10.1016/j.ympev.2017.02.001.

LUO L J, CHEN Q H, YANG L, et al . MSCs therapy reverse the gut microbiota in hypoxia-induced pulmonary hypertension mice[J ] . Front Physiol, 2021, 12: 712139. DOI: 10.3389/fphys.2021.712139.

VACCA M, CELANO G, CALABRESE F M, et al . The controversial role of human gut Lachnospiraceae[J ] . Microorganisms, 2020, 8(4): 573. DOI: 10.3390/microorganisms8040573.

LIU X M, MAO B Y, GU J Y, et al . Blautia-a new functional genus with potential probiotic properties?[J ] . Gut Microbes, 2021, 13(1): 1-21. DOI: 10.1080/19490976.2021.1875796.

MUKHOPADHYA I, HANSEN R, EL-OMAR E M, et al . IBD-what role do proteobacteria play?[J ] . Nat Rev Gastroenterol Hepatol, 2012, 9(4): 219-230. DOI: 10.1038/nrgastro.2012.14.

SUN D S, BAI R P, ZHOU W, et al . Angiogenin maintains gut microbe homeostasis by balancing α-Proteobacteria and Lachnospiraceae[J ] . Gut, 2021, 70(4): 666-676. DOI: 10.1136/gutjnl-2019-320135.

YI H, YU Q J, ZENG D F, et al. Serum inflammatory factor profiles in the pathogenesis of high-altitude polycythemia and mechanisms of acclimation to high altitudes[J ] . Mediators Inflamm, 2021, 2021: 8844438. DOI: 10.1155/2021/8844438.

DAI C H, KRANTZ S B, MEANS R T Jr, et al . Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3[J ] . J Clin Invest, 1991, 87(2): 391-396. DOI: 10.1172/JCI115009.

YANG Y C, CIARLETTA A B, TEMPLE P A, et al. Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3[J ] . Cell, 1986, 47(1): 3-10. DOI: 10.1016/0092-8674(86)90360-0.

LI P, HUANG J, TIAN H J, et al . Regulation of bone marrow hematopoietic stem cell is involved in high-altitude erythrocytosis[J ] . Exp Hematol, 2011, 39(1): 37-46. DOI: 10.1016/j.exphem.2010.10.006.

GANESAN V, VASUDEVAN D, JEYAPRAKASH R, KRISHNAN S. Blood microbiota and circulating microbial metabolites in diabetes and cardiovascular disease[J]. Trends Endocrinol Metab, 2020 31(11): 835-847. DOI: 10.1016/j.tem.2020.01.013.

GALLOWAY-P J R, JOBIN C. Microbiota influences on hematopoiesis and blood cancers: New horizons?[J]Blood Cancer Discov, 2023, 4(4): 267-275. DOI: 10.1158/2643-3230.BCD-22-0172.

浏览量

152

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据